Compare POOL & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | POOL | HALO |
|---|---|---|
| Founded | 1993 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 8.8B |
| IPO Year | 1997 | 2001 |
| Metric | POOL | HALO |
|---|---|---|
| Price | $186.25 | $66.19 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 11 |
| Target Price | ★ $274.43 | $78.64 |
| AVG Volume (30 Days) | 853.2K | ★ 1.2M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.38% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.45 | ★ 2.56 |
| Revenue | ★ $5,289,396,000.00 | $151,862,000.00 |
| Revenue This Year | $4.30 | $28.24 |
| Revenue Next Year | $3.84 | $12.56 |
| P/E Ratio | $129.61 | ★ $25.08 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $184.50 | $47.50 |
| 52 Week High | $345.00 | $82.22 |
| Indicator | POOL | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 30.22 | 52.53 |
| Support Level | N/A | $63.85 |
| Resistance Level | $250.38 | $68.00 |
| Average True Range (ATR) | 7.97 | 2.09 |
| MACD | -4.03 | 0.05 |
| Stochastic Oscillator | 2.67 | 49.75 |
Pool Corp is a wholesale distributor of swimming pool supplies, equipment, and related leisure products. The company's products include pool pumps, filters, heaters, and cleaners; pool maintenance products like chemicals, supplies, and repair parts; irrigation and landscape maintenance products; and outdoor lighting, grills, outdoor kitchen components, etc. These products are offered through branded distribution networks such as Horizon, SCP, Poolcorp Commercial Aquatics, Sun Wholesale Supply, Superior Pool Products, and NPT. The company's customers include pool builders, pool service companies, retail stores, commercial pool operators, and landscape contractors. Geographically, it generates maximum revenue from the United States, followed by other markets like Europe and Australia.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.